A detailed history of Tekla Capital Management LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Tekla Capital Management LLC holds 539,408 shares of ARDX stock, worth $4 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
539,408
Previous 539,408 -0.0%
Holding current value
$4 Million
Previous $2.58 Million 29.23%
% of portfolio
0.07%
Previous 0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$6.55 - $8.98 $447,299 - $613,244
-68,290 Reduced 11.24%
539,408 $4.09 Million
Q4 2019

Feb 13, 2020

BUY
$4.23 - $8.29 $105,750 - $207,249
25,000 Added 4.29%
607,698 $4.56 Million
Q3 2019

Nov 13, 2019

SELL
$2.15 - $6.28 $121,844 - $355,900
-56,672 Reduced 8.86%
582,698 $2.74 Million
Q2 2017

Aug 14, 2017

BUY
N/A
639,370
639,370 $3.26 Million

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $1.15B
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.